&quot;For patients with biopsy-conﬁrmed nonalcoholic steatohepatitis (NASH) and stage F2 or F3 ﬁbrosis, treatment with pegozafermin leads to improvements in ﬁbrosis. Study in @NEJMGroup. @DrLoomba @KowdleyMd @DLBHATTMD https://t.co/bSEYUP7Nzm&quot;

pegozafermin (BIO89-100) - 89Bio

Jul 14, 2023